Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

Abstract

Tocilizumab was not effective for preventing intubation or death in moderately ill hospitalized patients with Covid-19. Some benefit or harm cannot be ruled out, however, because the confidence intervals for efficacy comparisons were wide. (Funded by Genentech; ClinicalTrials.gov number, NCT04356937.).

Keywords

TocilizumabCoronavirus disease 2019 (COVID-19)MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakVirologyInternal medicineInfectious disease (medical specialty)Outbreak

Affiliated Institutions

Related Publications

Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia

Carlos Salama , Jian Han , Linda Yau +17 more

In hospitalized patients with Covid-19 pneumonia who were not receiving mechanical ventilation, tocilizumab reduced the likelihood of progression to the composite outcome of mec...

2020 New England Journal of Medicine 1297 citations

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results

Hongchao Pan , Richárd Pető , Ana‐Maria Henao‐Restrepo +71 more

These remdesivir, hydroxychloroquine, lopinavir, and interferon regimens had little or no effect on hospitalized patients with Covid-19, as indicated by overall mortality, initi...

2020 New England Journal of Medicine 2570 citations

Remdesivir for the Treatment of Covid-19 — Final Report

John H. Beigel , Kay M Tomashek , Lori E. Dodd +37 more

Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory trac...

2020 New England Journal of Medicine 7559 citations

Compassionate Use of Remdesivir for Patients with Severe Covid-19

Jonathan Grein , Norio Ohmagari , Daniel D. Shin +53 more

In this cohort of patients hospitalized for severe Covid-19 who were treated with compassionate-use remdesivir, clinical improvement was observed in 36 of 53 patients (68%). Mea...

2020 New England Journal of Medicine 2887 citations

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Yujun Tang , Jiajia Liu , Dingyi Zhang +3 more

Severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) is the pathogen that causes coronavirus disease 2019 (COVID-19). As of 25 May 2020, the outbreak of COVID-19 has cau...

2020 Frontiers in Immunology 1118 citations

Publication Info

Year: 2020
Type: article
Volume: 383
Issue: 24
Pages: 2333-2344
Citations: 1404
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1404

OpenAlex

Cite This

APA Style

                            
                                
                                    John H. Stone, 
                                
                                    Matthew J. Frigault, 
                                
                                    Naomi Serling‐Boyd
                                
                                et al.
                            
                            (2020). 
                            Efficacy of Tocilizumab in Patients Hospitalized with Covid-19. 
                            New England Journal of Medicine
                            , 383
                            (24)
                            , 2333-2344.
                            https://doi.org/10.1056/nejmoa2028836
                        

Identifiers

DOI: 10.1056/nejmoa2028836